Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II

200869 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: European Journal of Pharmacology

Volume 602, Issue 2-3, pp. 223-229

Field-Weighted Citation Impact: 1.79